Literature DB >> 7741839

Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods.

A M Choy1, D Darbar, C C Lang, T H Pringle, G P McNeill, N S Kennedy, A D Struthers.   

Abstract

OBJECTIVE: The SAVE study showed that captopril improves mortality in patients with left ventricular dysfunction after myocardial infarction and that this benefit occurred even in patients with no clinically overt heart failure. On the basis of this, it seems important to identify correctly which patients have left ventricular dysfunction after a myocardial infarction. The objective was to compare various methods of identifying patients with left ventricular dysfunction (left ventricular ejection fraction, LVEF, < or = 40%) after acute myocardial infarction. The methods compared were echocardiography (quantitative and qualitative visual assessment), clinical evaluation (subjective assessment and three clinical score methods), and measurement of plasma concentrations of cardiac natriuretic peptide hormones (atrial and brain natriuretic peptides, ANP and BNP).
DESIGN: Cross sectional study of left ventricular function in patients two to eight days after acute myocardial infarction.
SETTING: Coronary care unit of a teaching hospital. PATIENTS: 75 survivors of a recent myocardial infarction aged 40 to 88 with no history of cardiac failure and without cardiogenic shock at the time of entry to the study. MAIN OUTCOME MEASURES: Sensitivities and specificities of the various methods of detecting left ventricular dysfunction were calculated by comparing them with a cross sectional echocardiographic algorithm for LVEF.
RESULTS: Clinical impression was poor at identifying LVEF < 40% (sensitivity 46%). Clinical scoring improved this figure somewhat (modified Peel index sensitivity 64%). Qualitative visual assessment echocardiography was a more sensitive method (sensitivity 82%) for detecting LVEF < 40%. Plasma BNP concentration was also a sensitive measure for detecting left ventricular dysfunction (sensitivity 84%) but plasma ANP concentration was much poorer (sensitivity 64%).
CONCLUSION: Left ventricular dysfunction is easily and reliably detected by echocardiographic measurement of LVEF and also by a quick qualitative echocardiographic assessment but is likely to be missed by clinical assessment alone. High concentrations of plasma BNP maybe another useful indicator of left ventricular dysfunction, particularly in hospitals where not all patients can be screened by echocardiography or radionuclide ventriculography after myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7741839      PMCID: PMC1025420          DOI: 10.1136/hrt.72.1.16

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  41 in total

1.  Atrial and brain natriuretic peptides: a dual natriuretic peptide system potentially involved in circulatory homeostasis.

Authors:  C C Lang; A M Choy; A D Struthers
Journal:  Clin Sci (Lond)       Date:  1992-11       Impact factor: 6.124

2.  The prevention of heart failure--a new agenda.

Authors:  J N Cohn
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

Review 3.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

4.  Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction.

Authors:  M A Pfeffer; G A Lamas; D E Vaughan; A F Parisi; E Braunwald
Journal:  N Engl J Med       Date:  1988-07-14       Impact factor: 91.245

5.  Left ventricular volume and mass from single-plane cineangiocardiogram. A comparison of anteroposterior and right anterior oblique methods.

Authors:  J W Kennedy; S E Trenholme; I S Kasser
Journal:  Am Heart J       Date:  1970-09       Impact factor: 4.749

6.  Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction.

Authors:  N Sharpe; J Murphy; H Smith; S Hannan
Journal:  Lancet       Date:  1988-02-06       Impact factor: 79.321

7.  Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients.

Authors:  T Killip; J T Kimball
Journal:  Am J Cardiol       Date:  1967-10       Impact factor: 2.778

8.  Plasma concentration of atrial natriuretic peptide at admission and risk of cardiac death in patients with acute myocardial infarction.

Authors:  J Svanegaard; K Angelo-Nielsen; T Pindborg
Journal:  Br Heart J       Date:  1992-07

9.  Effect of haemodialysis on plasma levels of brain natriuretic peptide in patients with chronic renal failure.

Authors:  C C Lang; A M Choy; I S Henderson; W J Coutie; A D Struthers
Journal:  Clin Sci (Lond)       Date:  1992-02       Impact factor: 6.124

10.  Atrial natriuretic peptide after myocardial infarction.

Authors:  A C Tan; T T van Loenhout; E J Lamfers; T E Hooghoudt; P W Kloppenborg; T J Benraad
Journal:  Am Heart J       Date:  1989-09       Impact factor: 4.749

View more
  28 in total

Review 1.  Clinical case studies in heart failure management.

Authors:  R J MacFadyen; P Shiels; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1999-03       Impact factor: 4.335

Review 2.  Towards a blood test for heart failure: the potential use of circulating natriuretic peptides.

Authors:  S Talwar; P F Downie; L L Ng; I B Squire
Journal:  Br J Clin Pharmacol       Date:  2000-07       Impact factor: 4.335

Review 3.  Screening for left ventricular dysfunction: a step too far?

Authors:  T A McDonagh
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

Review 4.  Assessing the diagnostic test accuracy of natriuretic peptides and ECG in the diagnosis of left ventricular systolic dysfunction: a systematic review and meta-analysis.

Authors:  Clare Davenport; Elaine Yee Lan Cheng; Yip Tung Tony Kwok; Annie Hiu On Lai; Taka Wakabayashi; Chris Hyde; Martin Connock
Journal:  Br J Gen Pract       Date:  2006-01       Impact factor: 5.386

5.  Diagnosis of heart failure.

Authors:  J Cleland
Journal:  Heart       Date:  1998-06       Impact factor: 5.994

6.  Diagnostic accuracy of cardiothoracic ratio on admission chest radiography to detect left or right ventricular systolic dysfunction: a retrospective study.

Authors:  Harmeet S Chana; Claire A Martin; Holly E Cakebread; Felicia D Adjei; Parag R Gajendragadkar
Journal:  J R Soc Med       Date:  2015-07-07       Impact factor: 5.344

Review 7.  Neuroendocrine activation after myocardial infarction: causes and consequences.

Authors:  J G Cleland; P J Cowburn; K Morgan
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

8.  Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care.

Authors:  S J McClure; L Caruana; A P Davie; S Goldthorp; J J McMurray
Journal:  BMJ       Date:  1998-08-22

9.  Poor concordance of commonly used echocardiographic measures of left ventricular diastolic function in patients with suspected heart failure but preserved systolic function: is there a reliable echocardiographic measure of diastolic dysfunction?

Authors:  M C Petrie; K Hogg; L Caruana; J J V McMurray
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

10.  Echocardiographic assessment of left atrioventricular plane displacement as a complement to left ventricular regional wall motion evaluation in the detection of myocardial dysfunction.

Authors:  Ronnie Willenheimer; E Rydberg; M Stagmo; Petri Gudmundsson; Gerd Ericsson; Leif Erhardt
Journal:  Int J Cardiovasc Imaging       Date:  2002-06       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.